In the rush to modernize federal drug policy, federal regulators are on the verge of making a decision that will reverberate through American families for generations.
Reports indicate that President Donald Trump is considering reclassifying the federal status of marijuana from Schedule I to Schedule III, a much less dangerous class of drugs. Doing so would endanger our youth, misrepresent the current science, and prioritize the bottom line of a commercial industry over the health of Americans.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.